% | $
Quotes you view appear here for quick access.

Pluristem Therapeutics, Inc. Message Board

  • mdplanet Jul 28, 2014 7:19 AM Flag

    Regarding Zami....

    In the almost 4 years of following this company, not once, and I repeat, NOT ONCE, has Zami spoken to the general investment community. Two compassionate use patients die, his response was an interview with a local paper, this after he put 12M shares on the market. Their lead trial is put on hold & later lifted, only a PR. Earnings are released every 3 months, ne'er a word. His annual letters to the shareholders, blah, blah, blah.

    His redundant and ambiguous presentations are the same old song and dance time and again. He is a typical engineer who puts the cart before the horse. Spend a little more effort on getting an indication approved, instead of diverting their much needed funds to extending shelf life, etc.. Win approval, generate revenue, then advance the technology. It's been almost a year since the IC trial has been lifted and we still can't enroll the 76 remaining patients, even with multiple centers and 4 countries involved? Perhaps Zami prefers secrecy over informing his investors?

    It's apparent that I'm not the only one who feels this way as over 20% of the voters at the annual meeting had agreed he should go. He can't win over a single institution to take a major stake in this company.

    Yes, I can be cynical and sarcastic, but I am also a realist at the same time. I get tired of "news today," "news tomorrow, " & all the "giddy up's." Not unlike Zami, Allo's firm applies deception and speculation as they twist things around in their favor. I only look at the facts and attempt to raise questions others may be afraid to ask.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
1.79+0.02(+1.13%)Apr 29 4:00 PMEDT